首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Predicting 12-month mortality for peritoneal dialysis patients using the 'surprise' question.
【24h】

Predicting 12-month mortality for peritoneal dialysis patients using the 'surprise' question.

机译:使用“惊奇”问题预测腹膜透析患者的12个月死亡率。

获取原文
获取原文并翻译 | 示例
           

摘要

Studies in hemodialysis patients suggest that the "surprise" question can help to identify a group of patients with a high mortality risk who should receive priority for palliative care interventions. However, the same instrument has not been tested in peritoneal dialysis (PD) patients.We studied 367 prevalent PD patients from a single dialysis center. Three clinicians independently answered the "surprise" question (Would I be surprised if this patient died within the next 12 months?) according to their clinical impression of the individual patient. Patients are then classified into "yes" (yes, surprised) and "no" (no, not surprised) groups. All patients were followed for 12 months.In this cohort, 109 patients (29.7%) were allocated to the "no" group, and 258 (70.3%), to the "yes" group. Patients in the "no" group were older and had high prevalences of pre-existing ischemic heart disease, cerebrovascular disease, and peripheral vascular disease. The "no" group had a higher score on the Charlson comorbidity index and a higher malnutrition-inflammation score. At 12 months, 44 patients had died. Mortality was 24.8% in the "no" group and 6.6% in the "yes" group. Multivariate analysis showed that an opinion of "Not surprised if dies in the next 12 months" was an independent predictor of 12-month mortality, with an associated 3.594 excess mortality risk (95% confidence interval: 1.411 to 9.151; p = 0.007). The positive predictive value of this opinion was 24.8%, and its negative predictive value was 93.4%.The "surprise" question has the potential to help identify a group of PD patients with high short-term mortality. Its use may contribute to a decision to refer PD patients for early palliative care assessment.
机译:血液透析患者的研究表明,“惊奇”问题可以帮助确定一组具有高死亡风险的患者,应优先考虑姑息治疗干预措施。但是,该仪器尚未在腹膜透析(PD)患者中进行过测试。我们从一个透析中心研究了367名流行的PD患者。三名临床医生根据他们对每个患者的临床印象独立回答了“惊奇”问题(如果这个患者在接下来的12个月内死亡,我会感到惊讶吗?)。然后将患者分为“是”(是,惊讶)和“否”(否,不惊讶)组。所有患者均接受了12个月的随访。在该队列中,将109例患者(29.7%)分配给“否”组,将258例(70.3%)分配给“是”组。 “否”组中的患者年龄较大,并具有较高的既往缺血性心脏病,脑血管疾病和周围血管疾病的患病率。 “否”组在查尔森合并症指数上得分更高,而营养不良-炎症得分更高。在12个月时,有44名患者死亡。 “否”组的死亡率为24.8%,“是”组的死亡率为6.6%。多变量分析表明,“如果在接下来的12个月内死亡,不要感到惊讶”是12个月死亡率的独立预测因素,并伴有3.594的额外死亡风险(95%置信区间:1.411至9.151; p = 0.007)。该意见的阳性预测值为24.8%,阴性预测值为93.4%。“惊喜”问题有可能帮助识别一组短期死亡率高的PD患者。它的使用可能有助于决定将PD患者转诊至早期姑息治疗评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号